Who thinks adding more reps to sell Vraylar in primary care is idiotic

I seriously think upper management is totally clueless to think it makes good business sense to add yet another rep to sell Vraylar in primary care offices. If this was such a great market to sell antipsychotics wouldn’t Rexulti and Latuda have reps selling there too?? Abilify had augmenting MDD indication for quite awhile before it went generic yet didn’t use resources to market there. I already have quite a few pcp on my panel that show up for 3 or less antipsychotics written in a 13 week period and they look at me like I have lost my mind asking them to use Vraylar. Now we are going to have even lower volume targets added??? Makes no sense at all

 

They....... have........lost......their......fucking........minds. Horrible move, unnecessary and no, they will not get the 2 Rx's from each target (on average) to make this profitable. The company is making a mistake.

 

Vraylar is not a primary care drug. period. They are not trained to differentiate bipolar among all the other mood disorders.

 

this looks so bad!!!!

 

Clearly Management is out of touch with access issues in primary care. Most primary care reps run out of providers to see mid week because of all the bogus providers in their panels and access issues with ones on panel. To add another rep in this space makes no sense at all!!! Reps will be competing with each other to get in front of the few they can access. This is the part if the job most reps hate the most...trying to figure out who they can see that will make a difference. Wake up management

 

THIS!

 

do you really think that anyone that has anything to do with the “sales force” makes or has any input on these kinds of decisions!?!? Hell no. People with actual business experience wouldn’t let these brain dead lumps anywhere near the conversation! Don’t get me wrong they’d do something even more colossally stupid than this given the chance.

Our DMs, RDs, VPs, Carey Renner and whatever else are playing telephone, they get marching orders. The only thing these shit heads decide is who to put on a PIP and even then they have to have an OK from HR.

 

it is the stupidest plan ever. Allergan is going to make up a completely new market for an atypical antipsychotics. Adding on more primary care targets to our panels with even less market volume is such a waste of resources. Also makes it so obvious that we are pushing to use for depression. Antipsychotics have been out for decades and haven’t targeted these jokers yet we are taking the risk of adding contract reps and pcp reps with no CNS experience to sell an antipsychotic. Does management really think a hallway detail and leaving samples is going to change habits. Such a complete joke

 

They are willing to push reps and risk selling in "gray" areas. They don't care. Abilify, Serequel, Zyprexa... they all paid out fines for illegal promotion. Anyone think Allergan is different?

 

one of the stupidest ideas ever! Upper management has no clue. Primary care access sucks in most markets so putting more reps there is insane especially since most PCPs will never initiate therapy with an antipsychotic

 

compleye joke!

 

Hiring contract reps with no pharma experience to sell Vraylar is such a dumb move and waste of company resources. What group of clowns devised this plan?How are they going to represent Allergan and promote it when they have no clue on the disease state or products used to treat mental illness. How are the going to make primary care providers feel comfortable using an antipsychotic when they aren’t comfortable with the knowledge it takes to hold high level discussions? The company is so clueless. They must think by leaving samples on the shelf that primary care doctors will start writing an antipsychotic. And where are they going to dig up these “unique” targets they speak of ??? There are no primary care providers currently left off reps calls panels that are accessible!

 

Stop complaining and criticizing management. If you were as smart as you think, you would be there.
Now, go build bridges and get the shareholders paid!!!!!!!!

Thanks

 

What happens to the reps in these situations?

 

That interview process was interesting. Interviews were all over the place. And you guys are right. The main concern is how to get PCPs to write scripts when they would typically refer out to a specialist

 

Did anyone get a solid offer after the interviews yet? Or are they keeping everyone waiting for an email at the end of the week?

 

Dude you’re overthinking it. This is happening because you left samples at like 2 offices a day. While you’re sooooo concerned about how Allergan is going to be represented, the disease state, blah blah blah. They need people to stock the shelf you failed to stock now go out and hire people to do more then you and pay them less.

 

Was most impressed with that Allergan wants reps who dont know each other, to sell a mental health drug, in a me too movement to room together...now whose bright idea was that?

 

i thought the syneos contract was actually paying reps more than the direct hires, correct?